IHS Chemical Week

People & Business :: Green Issues

'Patent Box' Legislation Attracts GSK to Invest $776 Million in U.K.

9:03 AM MST | November 30, 2010 | Alex Scott

Legislation proposed this week by the U.K. government to encourage the development of intellectual property (IP) and manufacturing in the U.K. has led GlaxoSmithKline (GSK) to announce a £500 million ($776 million) investment in R&D and manufacturing in the country.   GSK’s package of planned investments features a £50 million U.K. venture capital fund for early stage healthcare companies and university spin outs; formation of a green chemistry academy at the University of Nottingham (Nottingham, U.K.); additional investment in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa